Literature DB >> 16520184

Reconstructive surgery for segmental arterial mediolysis involving both the internal carotid artery and visceral arteries.

Hideaki Obara1, Kenji Matsumoto, Yoshiaki Narimatsu, Hitoshi Sugiura, Masaki Kitajima, Toshihiro Kakefuda.   

Abstract

Segmental arterial mediolysis (SAM) is a rare, nonatherosclerotic, noninflammatory arteriopathy. A 52-year-old man with sudden hemiparesis of the right side was found to have an aneurysm of the left internal carotid artery and concomitant multiple aneurysms of the extrahepatic, celiac, and superior mesenteric arteries. Reconstructive operations using autologous vein graft were performed to treat the aneurysms. The histopathology analyses of resected arterial and aneurysmal specimens showed characteristics consistent with SAM. To our knowledge, a successfully treated case of SAM affecting both the carotid artery and visceral arteries has not previously been described.

Entities:  

Mesh:

Year:  2006        PMID: 16520184     DOI: 10.1016/j.jvs.2005.11.033

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

Review 1.  Subarachnoid and intraperitoneal hemorrhage secondary to segmental arterial mediolysis: A case report and review of the literature.

Authors:  Brian T Welch; Waleed Brinjikji; Andrew H Stockland; Giuseppe Lanzino
Journal:  Interv Neuroradiol       Date:  2017-04-26       Impact factor: 1.610

2.  Pancreaticoduodenal artery pseudoaneurysm caused by segmental arterial mediolysis: a case report of surgical treatment.

Authors:  Tomoki Ushijima; Akihiko Izumo; Takashi Matsumoto; Kenichiro Taniguchi; Takayuki Uchida
Journal:  Ann Vasc Dis       Date:  2013-04-20

3.  Segmental arterial mediolysis.

Authors:  Christine P Chao
Journal:  Semin Intervent Radiol       Date:  2009-09       Impact factor: 1.513

4.  Acute remodeling of an adjoining aneurysm after endovascular treatment of a ruptured splanchnic arterial aneurysm: a case of clinically diagnosed segmental arterial mediolysis.

Authors:  Yoshitaka Nishikawa; Katsuyuki Hoshina; Hiroki Sasaki; Akihiro Hosaka; Kota Yamamoto; Hiroyuki Okamoto; Kunihiro Shigematsu; Tetsuro Miyata
Journal:  Ann Vasc Dis       Date:  2012-11-15

5.  A case report of segmental arterial mediolysis in which computed tomography angiography was useful for diagnosis.

Authors:  Haruka Yoshida; Katsuaki Ukai; Mikako Sugimura; Hiromichi Akoshima; Kenji Kimura; Masahiro Iwabuchi; Keiichi Tadokoro; Hiroki Takahashi; Hiroya Rikimaru; Toshihiro Saitoh; Hiroyoshi Suzuki
Journal:  Clin J Gastroenterol       Date:  2013-11-06

Review 6.  Rare Mesenteric Arterial Diseases: Fibromuscular Dysplasia and Segmental Arterial Mediolysis and Literature Review.

Authors:  Masayoshi Ko; Kenya Kamimura; Akira Sakamaki; Yusuke Niwa; Kentaro Tominaga; Kenichi Mizuno; Shuji Terai
Journal:  Intern Med       Date:  2019-07-22       Impact factor: 1.271

7.  Longitudinal Evaluation of Segmental Arterial Mediolysis in Splanchnic Arteries: Case Series and Systematic Review.

Authors:  Hyun Soo Kim; Sang-Il Min; Ahram Han; Chanjoong Choi; Seung-Kee Min; Jongwon Ha
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

Review 8.  Concomitant Retroperitoneal and Subarachnoid Hemorrhage Due to Segmental Arterial Mediolysis : Case Report and Review of the Literature.

Authors:  V Hellstern; M Aguilar Pérez; P Kohlhof-Meinecke; H Bäzner; O Ganslandt; H Henkes
Journal:  Clin Neuroradiol       Date:  2017-11-03       Impact factor: 3.649

Review 9.  Diagnosis and management of fibromuscular dysplasia and segmental arterial mediolysis in gastroenterology field: A mini-review.

Authors:  Masayoshi Ko; Kenya Kamimura; Kohei Ogawa; Kentaro Tominaga; Akira Sakamaki; Hiroteru Kamimura; Satoshi Abe; Kenichi Mizuno; Shuji Terai
Journal:  World J Gastroenterol       Date:  2018-08-28       Impact factor: 5.742

Review 10.  Current management strategies for visceral artery aneurysms: an overview.

Authors:  Hideaki Obara; Matsubara Kentaro; Masanori Inoue; Yuko Kitagawa
Journal:  Surg Today       Date:  2019-10-16       Impact factor: 2.549

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.